跳至主要内容
临床试验/CTRI/2024/09/073333
CTRI/2024/09/073333已完成不适用

A study to evaluate the Skin characterization in healthy female participants through Facial image collection and Analysis in India

Unilever Research & Development1 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2024年9月9日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
450
试验地点
1
主要终点
Checking the aging characteristics from women of age range 18 to 65 years old using facial images captured by VISIA CR instrument

研究概览

简要总结

Title Evaluation of Skin Characteristics in Healthy Female Participants through Facial Image Collection and Analysis in India

Objective To explore and understand the skin characteristics of Indian females across different age groups using facial image analysis. This study aims to contribute to the development of the Bad Ager model and refine skincare technologies for the Consumer Benefit Platform (CBP).

 Methodology

 Participants: 450 healthy Indian females of varying ages.

Image Collection: Facial images captured with the VISIA CR-05 system, including Standard 1, Standard 2, Raked, CP, PP, and UV modes, from both side and front views.

Parameters: Analysis of lines/wrinkles, skin color, blemish color, pore size, gloss, and overall texture.

 Expected Outcomes: Insights into age-related skin characteristics specific to Indian females, aiding in the advancement of targeted skincare solutions and technological innovations.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • Indian females, age between 18-65 Be in general good health Understand the test procedure, read, and sign an appropriate Informed Consent Form indicating their willingness to participate in case of any difficulty in signing the ICF by the participant and LAR will sign the ICF on behalf of the participant Participants need to be competent that is able to understand what is to take place and able to provide a free decision on agreeing to the activity or taking part in the study on this Participants must be able to read and understand study instructions and any other relevant study documents Willing to follow the lifestyle and dietary restrictions.
  • The participants are divided into 5 different age groups, specific inclusion criteria for each age group mentioned in the below 18 to 29 100 participants 50 participants with mild to moderate condition of either one the aging signs or different combination of the aging signs on hyperpigmentation enlarged pores under eye dark circle etc.
  • at the discretion of the study dermatologist 50 participants not restriction with above criteria 30-39 100 participants cover mild to moderate condition of either one or different aging signs as on hyperpigmentation, enlarged pores, under eye dark circle, lines or wrinkles lack of skin glow or radiance at the discretion of the study dermatologist 40-49 100 participants cover any of the aging signs as hyperpigmentation lines or wrinkles scale with mild, moderate to severe condition lack of skin radiance, enlarged pores, sagging etc at the discretion of the study dermatologist 50-59 100 participants 100 participants cover any of the aging signs as hyperpigmentation lines or wrinkles scale with mild moderate to severe condition lack of skin radiance, enlarged pores, sagging etc at the discretion of the study dermatologist 60-65 50 participants 100 participants 100 participants cover any of the aging signs as hyperpigmentation, lines or wrinkles scale with mild, moderate to severe condition lack of skin radiance, enlarged pores, sagging etc at the discretion of the study dermatologist.

排除标准

  • Have used any skin lightening or anti-aging benefits products or any other dermatological treatment at least one month before this study Participant having done facial injections and or aesthetic surgery Be involved in any aspect of test administration that is evaluating or overseeing activities related to product Have participated in any clinical study involving the test sites within the previous 6 months or is participant participating in any clinical study concurrently Have a history of any type of cancer, including but not limited to any type of skin cancer squamous or basal cell carcinoma at the treatment site or history of malignant melanoma at any body site Have a history of skin disease or the presence of a skin condition on the test sites that the Investigator feels would interfere with the study Be taking antihistamines greater than 3x or week or anti-inflammatory greater than 8x or week on a regular basis or has the participant taken systemic or topical steroidal medications within 4 weeks of study enrolment Have any of the following conditions or factors that the investigator believes may affect the response of the skin or the interpretation of the test results including but not limited to diabetes pregnancy and lactation Have any cuts/abrasions on the test site at baseline Have had a suspicious skin lesion removed by a dermatologist at any time for face The participant is an employee of a sponsor or the site conducting the study.

结局指标

主要结局

Checking the aging characteristics from women of age range 18 to 65 years old using facial images captured by VISIA CR instrument

时间窗: Single day study

次要结局

  • NA(NA)

研究者

发起方
Unilever Research & Development
申办方类型
Other [Cosmetic company]
责任方
Principal Investigator
主要研究者

Dr Pranami Kashyap

CIDP Biotech India Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验